Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 4
417
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Some sulfonamides as aldose reductase inhibitors: therapeutic approach in diabetes

&
Pages 979-984 | Received 01 Feb 2020, Accepted 09 Mar 2020, Published online: 23 Mar 2020

References

  • Akbaba, Y., et al., 2014. Carbonic anhydrase inhibitory properties of novel sulfonamide derivatives of aminoindanes and aminotetralins. Journal of enzyme inhibition and medicinal chemistry, 29 (1), 35–42.
  • Akıncıoğlu, A., et al., 2014. Novel sulphamides and sulphonamides incorporating the tetralin scaffold as carbonic anhydrase and acetylcholine esterase inhibitors. Archiv der Pharmazie, 347 (1), 68–76.
  • Alexiou, P. and Demopoulos, V.J., 2010. A diverse series of substituted benzenesulfonamides as aldose reductase inhibitors with antioxidant activity: design, synthesis, and in vitro activity. Journal of medicinal chemistry, 53 (21), 7756–7766.
  • Alim, Z., et al., 2017. Inhibition behaviors of some phenolic acids on rat kidney aldose reductase enzyme: an in vitro study. Journal of enzyme inhibition and medicinal chemistry, 32 (1), 277–284.
  • Aslan, H.E. and Beydemir, S., 2017. Phenolic compounds: the inhibition effect on polyol pathway enzymes. Chemico-biological interactions, 266, 47–55.
  • Baran, W., et al., 2011. Effects of the presence of sulfonamides in the environment and their influence on human health. Journal of hazardous materials, 196, 1–15.
  • Bhattacharjee, M.K., 2016. Antimetabolites: antibiotics that inhibit nucleotide synthesis. Basel: Springer International Publishing, 95–108.
  • Bicer, A., et al., 2020. Synthesis of novel β-amino carbonyl derivatives and their inhibition effects on some metabolic enzymes. Journal of molecular structure, 1202, 127297.
  • Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical biochemistry, 72 (1–2), 248–254.
  • Caglayan, C., et al., 2018. The effects of hesperidin on sodium arsenite-induced different organ toxicity in rats on metabolic enzymes as antidiabetic and anticholinergics potentials: a biochemical approach. Journal of food biochemistry, 43 (2), e12720.
  • Cerelli, M.J., et al., 1986. Anti-inflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids. Journal of medicinal chemistry, 29 (11), 2347–2351.
  • Chen, X., et al., 2012. Sulfonyl group-containing compounds in the design of potential drugs for the treatment of diabetes and its complications. Current medicinal chemistry, 19 (21), 3578–3604.
  • Cheung, A.K., et al., 2005. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes, 54 (11), 3119–3125.
  • Çağlayan, C., et al., 2019. The effects of zingerone against vancomycin-induced lung, liver, kidney and testis toxicity in rats: the behavior of some metabolic enzymes. Journal of biochemical and molecular toxicology, 33 (10), e22381.
  • Demir, Y., 2019. The behaviour of some antihypertension drugs on human serum paraoxonase-1: an important protector enzyme against atherosclerosis. Journal of pharmacy and pharmacology, 71 (10), 1576–1583.
  • Demir, Y., Dikbaş, N., and Beydemir, Ş., 2018a. Purification and biochemical characterization of phytase enzyme from Lactobacillus coryniformis (MH121153). Molecular biotechnology, 60 (11), 783–790.
  • Demir, Y., et al., 2020. The influence of some nonsteroidal anti-inflammatory drugs on metabolic enzymes of aldose reductase, sorbitol dehydrogenase, and α-glycosidase: a perspective for metabolic disorders. Applied biochemistry and biotechnology, 190 (2), 437–447.
  • Demir, Y., et al., 2019a. Antidiabetic properties of dietary phenolic compounds: inhibition effects on α-amylase, aldose reductase, and α-glycosidase. Biotechnology and applied biochemistry, 66 (5), 781–786.
  • Demir, Y. and Köksal, Z., 2019. The inhibition effects of some sulfonamides on human serum paraoxonase-1 (hPON1). Pharmacological reports, 71 (3), 545–549.
  • Demir, Y., et al., 2017a. Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidney. Journal of biochemical and molecular toxicology, 31 (9), e21935.
  • Demir, Y., et al., 2018b. Antidiabetic potential: in vitro inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes. Archiv der pharmazie, 351 (12), e1800263.
  • Demir, Y., et al., 2019b. Inhibition effects of quinones on aldose reductase: antidiabetic properties. Environmental toxicology and pharmacology, 70, e103195.
  • Demir, Y., et al., 2017b. Phytase from Weissella halotolerans: purification, partial characterisation and the effect of some metals. International journal of food properties, 20 (2), 2127–2137.
  • Elosta, A., Ghous, T., and Ahmed, N., 2012. Natural products as anti-glycation agents: possible therapeutic potential for diabetic complications. Current diabetes reviews, 8 (2), 92–108.
  • Erdemir, F., et al., 2019. Novel 2-aminopyridine liganded Pd(II) N-heterocyclic carbene complexes: synthesis, characterization, crystal structure and bioactivity properties. Bioorganic chemistry, 91, 103134.
  • Gocer, H., et al., 2017. Carbonic anhydrase inhibitory properties of phenolic sulfonamides derived from dopamine related compounds. Arabian journal of chemistry, 10, 398–402.
  • Göçer, H.,et al., 2013. Synthesis, antioxidant, and antiacetylcholinesterase activities of sulfonamide derivatives of dopamine-related compounds. Archive der pharmazie, 346 (11), 783–792.
  • Gokcen, T., et al., 2016. A class of sulfonamides as carbonic anhydrase I and II inhibitors. Journal of enzyme inhibition and medicinal chemistry, 31 (sup2), 180–188.
  • Gul, H.I., et al., 2016. Synthesis of 4-(2-substituted hydrazinyl) benzenesulfonamides and their carbonic anhydrase inhibitory effects. Journal of enzyme inhibition and medicinal chemistry, 31 (4), 568–573.
  • Gülcin, I., et al., 2020. Anticholinergic, antidiabetic and antioxidant activities of Anatolian pennyroyal (Mentha pulegium)-analysis of its polyphenol contents by LC-MS/MS. Biocatalysis and agricultural biotechnology, 23, 101441.
  • Gündoğdu, S., et al., 2019. New isoindole-1,3-dione substituted sulfonamides as potent inhibitors of carbonic anhydrase and acetylcholinesterase: design, synthesis, and biological evaluation. Chemistry select, 4 (45), 13347–13355.
  • Ho, E.C., et al., 2006. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage. Diabetes, 55 (7), 1946–1953.
  • Kador, P.F., Wyman, M., and Oates, P.J., 2016. Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®). Progress in retinal and eye research, 54, 1–29.
  • Kato, K., et al., 1991. Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in rats. European journal of pharmacology, 193 (2), 185–191.
  • Köksal, Z., et al., 2017. Secondary sulfonamides as effective lactoperoxidase inhibitors. Molecules, 22 (6), 793.
  • Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227 (5259), 680–685.
  • Lineweaver, H. and Burk, D., 1934. The determination of enzyme dissociation constants. Journal of the American chemical society, 56 (3), 658–666.
  • Mete, E., et al., 2016. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides. Journal of enzyme inhibition and medicinal chemistry, 31 (sup2), 1–5.
  • Pollreisz, A. and Schmidt-Erfurth, U., 2010. Diabetic cataract-pathogenesis epidemiology and treatment. Journal of ophthalmology, 2010, 1–8.
  • Sağlık, B.N., et al., 2019. Synthesis, molecular docking analysis and carbonic anhydrase I-II inhibitory evaluation of new sulfonamide derivatives. Bioorganic chemistry, 91, 103153.
  • Taslimi, P., et al., 2017. Synthesis and bioactivity of several new hetaryl sulfonamides. Journal of enzyme inhibition and medicinal chemistry, 32 (1), 137–145.
  • Taslimi, P., et al., 2018. Diarylmethanon, bromophenol and diarylmethane compounds: discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia. International journal of biological macromolecules, 119, 857–863.
  • Taslimi, P., et al., 2019. The antidiabetic and anticholinergic effects of chrysin on cyclophosphamide-induced multiple organs toxicity in rats: pharmacological evaluation of some metabolic enzymes activities. Journal of biochemical and molecular toxicology, 33 (6), e22313.
  • Türkeş, C., Demir, Y., and Beydemir, Ş., 2019b. Anti-diabetic properties of calcium channel blockers: inhibition effects on aldose reductase enzyme activity. Applied biochemistry and biotechnology, 189 (1), 318–329.
  • Türkeş, C., et al., 2019a. Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorganic chemistry, 89, 103004.
  • Xi, M., et al., 2008. Antioxidant and antiglycation properties of total saponins extracted from traditional Chinese medicine used to treat diabetes mellitus. Phytotherapy research, 22 (2), 228–237.
  • Yıldırım, A., et al., 2015. N-Acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes I and II. Bioorganic and medicinal chemistry, 23 (10), 2598–2605.
  • Yigit, M., et al., 2020. Novel amine-functionalized benzimidazolium salts: Synthesis, characterization, bioactivity, and molecular docking studies. Journal of molecular structure, 1207, 127802.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.